BACKLOG CLEARANCE NEWSLETTER COMMUNICATION
The Backlog Clearance Team has been made aware of a miscommunication in our Newsletter dated August ...
19 November, 2020
News & Updates
-
-
HEALTH PRODUCT APPLICATION STATUS CHECKER
SAHPRA has implemented an application status checker. This new tool is listed under “Online Services...
03 November, 2020 -
SAHPRA APPROVES SARS-Cov-2 SEROLOGY TEST KITS
Embargo: Immediate release AHPRA has issued Section 21 authorisation for one serological test kit (r...
25 August, 2020 -
COMMUNICATION TO STAKEHOLDERS – COVI-VIG REPORTING SYSTEM
In the interest of public health, SAHPRA has launched the COVI-Vig reporting system for vigilanceand...
20 August, 2020
SAHPRA TV and Podcasts
Stay up to date with our latest news, media coverages, interviews and announcements on SAHPRA TV.
Safety alerts
Medicine safety alert: new restrictions on the use of gamma benzene hexachloride (lindane) – containing shampoos
May 2009
The Medicines Control Council (MCC) alerts all health care professionals to the correct route of administration of Rotarix vaccine.
March 2008
The Medicines Control Council (MCC) alerts all health care professionals to new prescribing information for promethazine.
September 2007
MSA Ketoconazole And Domperidone
MEDICINE SAFETY ALERT: INTERACTION BETWEEN KETOCONAZOLE AND DOMPERIDONE AND THE RISK OF QT PROLONGATION
March 2008
PRODUCT RECALLS
Procter & Gamble South African Trading (Pty) Ltd, in consultation with the Medicines Control Council, wishes to alert the public that a small amount of counterfeit Vicks…
10 February 2017
This recall is initiated as a result of product quality complaint logged with Aspen Pharmacare due to the discloration of Lethyl 30 mg tablets
31 July 2015
Following a customer complaint, we have identified the vitamin premix used in the manufacture of the affected product and batches contain additional vitamins and minerals
October 25, 2019
Johnson & Johnson (Pty) Ltd, in consultation withe Medicine Control Council, is recalling the following batches of BENYLIN® products
1 July 2015
Publications
ANNUAL REPORT
The annual report has been prepared in accordance with the guidelines on the annual report as issued by the National Treasury.
2018/19
Cannabis and related substances A5 final
CANNABIS AND RELATED SUBSTANCES
25 October 2019
Registrations of Medicines
NOTIFICATION OF REGISTRATION OF MEDICINES BY THE ACTING CEO OF SAHPRA IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
October 2019
THC and CBD Information page
SOCIAL MEDIA FEEDS
SPOTLIGHT on #vaccines. Before any vaccines can be delivered to priority populations—or marketed through the priv sector—their use must be authorised by @SAHPRA1.
https://www.news24.com/citypress/news/covid-19-how-vaccine-registration-will-work-in-sa-20201123